These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9682970)

  • 1. Immune stimulating complexes as mucosal vaccines.
    Smith RE; Donachie AM; Mowat AM
    Immunol Cell Biol; 1998 Jun; 76(3):263-9. PubMed ID: 9682970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral vaccination with immune stimulating complexes.
    Mowat AM; Smith RE; Donachie AM; Furrie E; Grdic D; Lycke N
    Immunol Lett; 1999 Jan; 65(1-2):133-40. PubMed ID: 10065639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens.
    Mowat AM; Maloy KJ; Donachie AM
    Immunology; 1993 Dec; 80(4):527-34. PubMed ID: 7508416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes.
    Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
    Immunology; 2003 Sep; 110(1):95-104. PubMed ID: 12941146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of local innate immune responses and modulation of antigen uptake as mechanisms underlying the mucosal adjuvant properties of immune stimulating complexes (ISCOMS).
    Furrie E; Smith RE; Turner MW; Strobel S; Mowat AM
    Vaccine; 2002 May; 20(17-18):2254-62. PubMed ID: 12009281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
    Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
    Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses.
    Smith RE; Donachie AM; Grdic D; Lycke N; Mowat AM
    J Immunol; 1999 May; 162(9):5536-46. PubMed ID: 10228035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen.
    Mowat AM; Donachie AM; Jägewall S; Schön K; Löwenadler B; Dalsgaard K; Kaastrup P; Lycke N
    J Immunol; 2001 Sep; 167(6):3398-405. PubMed ID: 11544331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-gamma.
    Smith RE; Donachie AM; McLaren FH; Mowat AM
    Immunology; 1998 Apr; 93(4):556-62. PubMed ID: 9659229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.
    Lycke N
    Cell Microbiol; 2004 Jan; 6(1):23-32. PubMed ID: 14678328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and potential application of ISCOMs in veterinary medicine.
    Morein B; Hu KF; Abusugra I
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS.
    Maloy KJ; Donachie AM; Mowat AM
    Eur J Immunol; 1995 Oct; 25(10):2835-41. PubMed ID: 7589080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells.
    Helgeby A; Robson NC; Donachie AM; Beackock-Sharp H; Lövgren K; Schön K; Mowat A; Lycke NY
    J Immunol; 2006 Mar; 176(6):3697-706. PubMed ID: 16517738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for dendritic cells in the priming of antigen-specific CD4+ and CD8+ T lymphocytes by immune-stimulating complexes in vivo.
    Beacock-Sharp H; Donachie AM; Robson NC; Mowat AM
    Int Immunol; 2003 Jun; 15(6):711-20. PubMed ID: 12750355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iscom, a delivery system for parenteral and mucosal vaccination.
    Morein B; Villacrés-Eriksson M; Lövgren-Bengtsson K
    Dev Biol Stand; 1998; 92():33-9. PubMed ID: 9554257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens iscoms.
    Carol H; Nieto A
    Vet Immunol Immunopathol; 1998 Sep; 65(1):29-41. PubMed ID: 9802574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
    Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of virus-specific immunity by iscoms.
    Osterhaus AD; Rimmelzwaan GF
    Dev Biol Stand; 1998; 92():49-58. PubMed ID: 9554259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine.
    Aguila A; Donachie AM; Peyre M; McSharry CP; Sesardic D; Mowat AM
    Vaccine; 2006 Jun; 24(24):5201-10. PubMed ID: 16650917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.